Related Experiment Videos
Malignant melanomas of the iris
1University of Ankara, Faculty of Medicine, Eye Clinic, Ocular Oncology Department, Turkey.
Japanese Journal of Ophthalmology
|September 28, 1998
Summary
Recognizing iris melanoma is crucial due to similar-looking benign lesions. This study evaluated 41 patients, detailing features, treatments, and prognosis, with a low mortality rate observed.
Area of Science:
- Ophthalmology
- Oncology
- Dermatology
Background:
- Iris melanoma diagnosis is challenging due to resemblance with benign lesions.
- Accurate identification and management are vital for patient outcomes.
Purpose of the Study:
- To evaluate epidemiological, clinical, histopathological features, treatment, and prognosis of iris melanoma.
- To analyze management strategies and outcomes in a cohort of iris melanoma patients.
Main Methods:
- Retrospective analysis of 41 iris melanoma patients (1964-1996).
- Evaluation of tumor characteristics, treatment modalities (observation, sector iridectomy, iridocyclectomy, enucleation), and histopathology.
- Follow-up data including mortality rates and metastasis.
Main Results:
- The study included 41 patients (20 male, 21 female) with a mean age of 44.6 years.
- Treatment varied: observation (9), sector iridectomy (15), iridocyclectomy (6), enucleation (11). Some required further intervention.
- Histopathology revealed spindle cell (27), mixed cell (6), and epithelioid cell (2) types. Mortality rate was 2.4% over a mean 3.2-year follow-up.
Conclusions:
- Iris melanoma requires careful recognition and management.
- Treatment strategies should be tailored to tumor characteristics.
- Epithelioid cell type melanoma was associated with metastasis in one fatal case.